Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
ACS Omega
|
July 10, 2026
Synthesis and Investigation of a Novel Platinum(II) Complex Targeting Biotin Receptor-Positive Tumors: In Vitro Evaluation in Cisplatin-Sensitive and -Resistant Cells, Mass Cytometry Profiling, Pharmacokinetics, In Vivo Efficacy, and SMVT-Mediated Uptake
Natalia Kamperi, Nikolaos Saxonis, Eleni Skavatsou, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 18, 2023
Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer
Nikiana Simigdala, Anna Chalari, Aimilia D Sklirou, et al.
Pediatric Rheumatology Online Journal
|
January 28, 2025
Increased interferon I signaling, DNA damage response and evidence of T-cell exhaustion in a patient with combined interferonopathy (Aicardi-Goutières Syndrome, AGS) and cohesinopathy (Cornelia de Lange Syndrome, CdLS)
Sorina Boiu, Nikolaos Paschalidis, George Sentis, et al.
Frontiers in Immunology
|
June 19, 2025
Multiparametric analysis in the peripheral blood of Giant Cell Arteritis and Polymyalgia Rheumatica patients at the early phases of steroid treatment reveals changes in cell subpopulations and lipid mediators: a preliminary study
Dimitris Anastasios Palamidas, Maria Papadaki, Nikolaos Paschalidis, et al.
European Journal of Immunology
|
November 8, 2024
Characterization of the Molecular Signature of Human Monocytes in Aging and Myelodysplastic Neoplasms
Christina Maria Rimpa, Maria Grigoriou, Athanasios Tasis, et al.
Cancers
|
June 26, 2025
Integrative Molecular and Immune Profiling in Advanced Unresectable Melanoma: Tumor Microenvironment and Peripheral PD-1+ CD4+ Effector Memory T-Cells as Potential Markers of Response to Immune Checkpoint Inhibitor Therapy
Manuel Molina-García, María Jesús Rojas-Lechuga, Teresa Torres Moral, et al.
Annals of the Rheumatic Diseases
|
November 7, 2024
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways
Georgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, et al.
Annals of the Rheumatic Diseases
|
February 7, 2025
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways
Georgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, et al.
Nature Communications
|
March 30, 2024
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients
Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, et al.
Iscience
|
August 27, 2025
Blood immunomap for prediction of responses to anti-PD-1 immunotherapy in metastatic non-small cell lung cancer
Maria Semitekolou, Nikolaos Paschalidis, Domenico Lo Tartaro, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
ACS Omega
|
July 10, 2026
Synthesis and Investigation of a Novel Platinum(II) Complex Targeting Biotin Receptor-Positive Tumors: In Vitro Evaluation in Cisplatin-Sensitive and -Resistant Cells, Mass Cytometry Profiling, Pharmacokinetics, In Vivo Efficacy, and SMVT-Mediated Uptake
Natalia Kamperi, Nikolaos Saxonis, Eleni Skavatsou, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 18, 2023
Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer
Nikiana Simigdala, Anna Chalari, Aimilia D Sklirou, et al.
Pediatric Rheumatology Online Journal
|
January 28, 2025
Increased interferon I signaling, DNA damage response and evidence of T-cell exhaustion in a patient with combined interferonopathy (Aicardi-Goutières Syndrome, AGS) and cohesinopathy (Cornelia de Lange Syndrome, CdLS)
Sorina Boiu, Nikolaos Paschalidis, George Sentis, et al.
Frontiers in Immunology
|
June 19, 2025
Multiparametric analysis in the peripheral blood of Giant Cell Arteritis and Polymyalgia Rheumatica patients at the early phases of steroid treatment reveals changes in cell subpopulations and lipid mediators: a preliminary study
Dimitris Anastasios Palamidas, Maria Papadaki, Nikolaos Paschalidis, et al.
European Journal of Immunology
|
November 8, 2024
Characterization of the Molecular Signature of Human Monocytes in Aging and Myelodysplastic Neoplasms
Christina Maria Rimpa, Maria Grigoriou, Athanasios Tasis, et al.
Cancers
|
June 26, 2025
Integrative Molecular and Immune Profiling in Advanced Unresectable Melanoma: Tumor Microenvironment and Peripheral PD-1+ CD4+ Effector Memory T-Cells as Potential Markers of Response to Immune Checkpoint Inhibitor Therapy
Manuel Molina-García, María Jesús Rojas-Lechuga, Teresa Torres Moral, et al.
Annals of the Rheumatic Diseases
|
November 7, 2024
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways
Georgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, et al.
Annals of the Rheumatic Diseases
|
February 7, 2025
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways
Georgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, et al.
Nature Communications
|
March 30, 2024
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients
Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, et al.
Iscience
|
August 27, 2025
Blood immunomap for prediction of responses to anti-PD-1 immunotherapy in metastatic non-small cell lung cancer
Maria Semitekolou, Nikolaos Paschalidis, Domenico Lo Tartaro, et al.
Page
of 6